Showing results (1291-1300 of 1,886) with videos related to

Sort By:
Pageof 189
Journal of Neuro-Oncology|December 19, 2014
LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastasesKamran A Ahmed, Jessica M Freilich, Sarah Sloot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinomaJohn A Thompson, Brendan D Curti, Bruce G Redman, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 15, 2023
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Martin S Weber, et al.
Stem Cell Reports|August 2, 2024
Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributedOlivia J Stonehouse, Christine Biben, Tom S Weber, et al.
The Review of Scientific Instruments|February 7, 2025
Compact in-vacuum gamma-ray spectrometer for high-repetition rate PW-class laser-matter interactionG Fauvel, K Tangtartharakul, A Arefiev, et al.
Current Oncology Reports|February 19, 2005
Intensity-modulated radiotherapy: is xerostomia still prevalent?Mark S Chambers, Adam S Garden, David Rosenthal, et al.
Investigational New Drugs|January 19, 2010
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanomaEvan M Hersh, Steven J O'Day, John Powderly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim reportJ C Yang, S L Topalian, D Parkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.
Pageof 189